Consistent with the critical roles of Zn2+ in tau phosphorylation, the abnormal expression and distribution of zinc transporter 3 (ZnT3) have also been reported to cause AD via disrupting Zn2+ metabolism in synaptic vesicles [23-26]. Here, MAPT is linked to Alzheimer disease.